Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Eli Lilly and Company    LLY

ELI LILLY AND COMPANY

(LLY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • The company has solid fundamentals for a short-term investment strategy.
Strengths
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
  • Within the weekly time frame the stock shows a bullish technical configuration above the support level at 123.94 USD
Weaknesses
  • Stock prices approach a strong long-term resistance in weekly data at USD 146.41.
  • Technically, the stock approaches a strong medium-term resistance at USD 147.35.
  • Based on current prices, the company has particularly high valuation levels.
Ratings chart
Sector Pharmaceuticals - NEC
1st jan.Capitalisation (M$)Investor Rating
ELI LILLY AND COMPANY7.37%135 494
JOHNSON & JOHNSON2.92%395 123
ROCHE HOLDING AG9.79%294 912
NOVARTIS4.27%220 633
MERCK AND COMPANY-9.13%210 426
PFIZER-5.74%202 051
BRISTOL-MYERS SQUIBB COMPAN..2.94%149 421
NOVO NORDISK AS11.65%148 645
ABBVIE INC.6.22%139 083
AMGEN INC.-7.30%131 810
SANOFI2.92%125 396
ASTRAZENECA PLC-4.04%124 785
GLAXOSMITHKLINE-6.21%108 174
BAYER AG6.26%82 414
ALLERGAN PLC4.23%65 104
TAKEDA PHARMACEUTICAL COMPA..0.02%60 987
More Results
Financials (USD)
Sales 2020 23 964 M
EBIT 2020 7 401 M
Net income 2020 5 485 M
Debt 2020 10 799 M
Yield 2020 2,06%
P/E ratio 2020 22,4x
P/E ratio 2021 17,6x
EV / Sales2020 6,10x
EV / Sales2021 5,71x
Capitalization 135 B
Upcoming event on ELI LILLY AND COMPANY
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes